Guided Bone Regeneration Clinical Trial
— ObsR+Official title:
Prospective, National, Multicentre and Observational Clinical Investigation of R.T.R.+ Membrane Used in Guided Tissue Regeneration (GTR) in Dental Surgical Procedures
The goal of this observational study is to measure in real practice the performance and safety of RTR+Membrane, a synthetic dental membrane for guided tissue regeneration in periodontal or dental implant surgery. The main question it aims to answer is to measure the post-operative wound healing several months after surgery. Participants will be followed after their dental surgery via clinical examination and radiological and photos images.
Status | Recruiting |
Enrollment | 90 |
Est. completion date | December 2025 |
Est. primary completion date | December 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 89 Years |
Eligibility | Inclusion Criteria: - Male or female adult patient - Patient with one of the 3 following dental treatments to be done with the study device: post-extraction socket preservation, alveolar ridge augmentation, or Guided Tissue Regeneration (GTR) during immediate implant placement. - Patient affiliated or beneficiary of a social security system. - Patient has signed his/her informed consent form. Exclusion Criteria: - Pregnancy or lactation - Active tissue infection at the implant site - Several dental treatments done simultaneously in non-contiguous dental zones - Heavy smoker (>10 cigarettes / day) - Patient receiving long-term corticosteroid therapy, anti-rejection drugs, bisphosphonates, head & neck radiotherapy or chemotherapy - Patient with chronic infections (such as osteomyelitis) at the surgical site - Patient with poorly controlled metabolic disorders (such as diabetes, osteomalacia, thyroid disorders) - Patient with an auto-immune disease - Patient under tutelage, vulnerable person, person without liberty, or unable to complete questionnaire independently |
Country | Name | City | State |
---|---|---|---|
France | Hospital University of Nantes | Nantes | |
France | Private dental practice office of Dr. Alain Hoornaert | Nantes | |
France | Private dental practice office of Dr. Samer Saloum-Rouxel | Nantes | |
France | Private dental practice office of Dr. Xavier Struillou | Nantes | |
France | Private dental practice office of Dr. Edouard Lanoiselée | Nozay | |
France | Private dental practice office of Dr. Aurélien Fruchet | Olonne-sur-Mer | |
France | Private dental practice office of Dr. Hélène Le Hécho | Orée d'Anjou | |
France | Private dental practice office of Dr. Nicolas Strube | Orvault | |
France | Private dental practice office of Dr. Romain Besnier | Orvault |
Lead Sponsor | Collaborator |
---|---|
Septodont |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Post-operative wound healing measured by the Early Wound-Healing Index | For all groups
The Early Wound-Healing Index (EHI) has the following best to worst scoring: (EHI) 1: complete flap closure without fibrin line in the interproximal area. (EHI) 2: complete flap closure with fine fibrin line in the interproximal area. (EHI) 3: complete flap closure with fibrin clot in the interproximal area. (EHI) 4: incomplete flap closure with partial necrosis of the interproximal tissue. (EHI) 5: incomplete flap closure with complete necrosis of the interproximal tissue. The EHI is evaluated at the Visit 3 (late post-surgery follow-up) for the primary outcome measure. |
up to 6 months | |
Secondary | Post-operative wound healing measured by Early Wound-Healing Index | For all groups
The Early Wound-Healing Index (EHI) has the following best to worst scoring: (EHI) 1: complete flap closure without fibrin line in the interproximal area. (EHI) 2: complete flap closure with fine fibrin line in the interproximal area. (EHI) 3: complete flap closure with fibrin clot in the interproximal area. (EHI) 4: incomplete flap closure with partial necrosis of the interproximal tissue. (EHI) 5: incomplete flap closure with complete necrosis of the interproximal tissue. The EHI is evaluated at the Visit 2 for this secondary outcome measure. |
up to 14 days | |
Secondary | Post-operative wound healing measured by Early Wound Healing Score | For all groups
The Early Wound Healing Score is from 0 (worse) to 10 (best). The EHS is evaluated at the Visit 2 for this secondary outcome measure. |
up to 14 days | |
Secondary | Post-operative clinical exam | For all groups
This is a descriptive secondary outcome measured by the investigator via the reporting of the presence or the absence of: pain, discomfort, inflammation, hematoma, redness, swelling/suppuration, membrane exposure, dehiscence. The evaluation is done at visit 2, visit 2Bis, and visit 3. |
up to 6 months | |
Secondary | Number of adverse device effects (at least possibly) related to study device | For all groups | up to 6 months | |
Secondary | Oral Health-Related Quality of Life measured by the Oral Health Impact Profile (OHIP-5 items) | For all groups
The 5 items of OHIP are: Difficulty chewing any foods; Painful aching in the mouth; Felt uncomfortable about the appearance of teeth; Less flavor in the food; and, Difficulty doing the usual jobs. Score is from 0 (best) to 20 (worse). The evaluation is done at visit 2 and visit 3. |
up to 6 months | |
Secondary | Radiological measurements on CBCT | Only for Post-extraction socket preservation sub-group & for Alveolar ridge augmentation sub-group
The treatment efficacy is measured via the following measures on CBCT: A. Osseous changes in mesiodistal width of the alveolar ridge B. Osseous changes in height of the alveolar ridge C. Osseous changes in vestibulolingual dimension of the alveolar ridge. These changes are evaluated from Baseline to Visit 3. |
up to 6 months | |
Secondary | Radiological measurements on retro-alveolar radios | Only for Guided Tissue Regeneration (GTR) during immediate implant placement subgroup.
The treatment efficacy is measured via the following measures: A. Distal vertical situation of the bone plateau compared to the implant by retroalveolar radiography B. Mesial vertical situation of the bone plateau compared to the implant by retroalveolar radiography C. Insertion Torque Value (Ncm) These changes are evaluated from Baseline to Visit 3. |
up to 4 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06139939 -
Guided Bone Regeneration for Horizontal Alveolar Ridge Augmentation With Double Layer Technique
|
N/A | |
Not yet recruiting |
NCT03840681 -
Assessment of Guided Bone Regeneration in Atrophic Anterior Maxilla
|
N/A | |
Completed |
NCT05143242 -
Contour Augmentation by Means of Connective Tissue Grafting Versus Guided Bone Regeneration
|
N/A | |
Not yet recruiting |
NCT06286605 -
RCT GBR One Stages Comparing A-Oss and Autogenous Bone Versus A-Oss and LCR-A
|
N/A | |
Recruiting |
NCT03225495 -
Comparison Between Ultra-narrow Diameter Implants (2,75 mm) Without Bone Regeneration Versus Standard Diameter Implants (4,3 mm) in Combination With Bone Regeneration
|
N/A | |
Recruiting |
NCT06295055 -
Semi-rigid Shell Barrier System for Alveolar Bone Augmentation (SSBS for ABA)
|
N/A | |
Not yet recruiting |
NCT04679766 -
Evaluation of Ice Cream Cone Technique With Immediate Implant Placement in Patients With Labial Plate Dehiscence
|
N/A | |
Not yet recruiting |
NCT06257225 -
Evaluation of Horizontal Bone Gain in the Lower Posterior Partially Edentulous Patient Comparing the Stabilization of Membranes With and Without Tacs
|
N/A | |
Recruiting |
NCT05890469 -
Effect of Implant Surface Material and Topography on Bone Regeneration.
|
N/A | |
Recruiting |
NCT04451486 -
A Phase I Study of SB Cell for the Enhanced Osseointegration of Guided Bone Regeneration in Implant Surgery
|
Phase 1 |